Biostatistics and Research Methods for Ophthalmologists

Biostatistics and Research Methods for Ophthalmologists

Last updated: October 2026

Key points in 60 seconds

  • Sensitivity = TP/(TP+FN); a sensitive test, if negative, rules out (SnNout).
  • Specificity = TN/(TN+FP); a specific test, if positive, rules in (SpPin).
  • Predictive values depend on prevalence: screening in low-prevalence populations gives many false positives.
  • Know study designs, common biases, trial terms and agreement statistics for exams and journal club.

The statistics, study design and research ethics that appear in every ophthalmology exam and every journal club, explained with eye examples. Includes a calculator for diagnostic test accuracy.

Diagnostic tests: the 2 × 2 table

Disease presentDisease absent
Test positiveTrue positive (TP)False positive (FP)
Test negativeFalse negative (FN)True negative (TN)
  • Sensitivity = TP ÷ (TP + FN): of those with disease, how many test positive. A sensitive test, if negative, rules disease out (SnNout).
  • Specificity = TN ÷ (TN + FP): of those without disease, how many test negative. A specific test, if positive, rules disease in (SpPin).
  • Positive predictive value = TP ÷ (TP + FP) and negative predictive value = TN ÷ (TN + FN). These depend on prevalence: screening for glaucoma in the general population (low prevalence) gives many false positives even with a good test.
  • Likelihood ratios: LR+ = sensitivity ÷ (1 − specificity); LR− = (1 − sensitivity) ÷ specificity. Unlike predictive values, they do not change with prevalence.

The default numbers show a test with 90% sensitivity and 90% specificity used where prevalence is 2%: the positive predictive value is only about 16%.

Measures of effect

MeasureFormulaExample (event in 20% of controls, 15% of treated)
Absolute risk reduction (ARR)Control risk − treated risk20% − 15% = 5%
Relative risk (RR)Treated risk ÷ control risk0.15 ÷ 0.20 = 0.75
Relative risk reduction (RRR)1 − RR25%
Number needed to treat (NNT)1 ÷ ARR1 ÷ 0.05 = 20
Odds ratio (OR)(a × d) ÷ (b × c) from a 2 × 2 tableUsed in case–control studies; close to RR when the outcome is rare
  • Confidence interval: the range of values compatible with the data. If a 95% CI for an RR or OR includes 1 (or for a difference includes 0), the result is not statistically significant at p < 0.05.
  • p-value: the probability of a result at least this extreme if there were truly no difference. It does not measure the size or importance of an effect.
  • Type I error (α): finding a difference that is not real (false positive). Type II error (β): missing a real difference. Power = 1 − β, usually set at 80–90%; it rises with sample size and effect size.

Study designs and the evidence pyramid

DesignWhat it doesEye exampleMain weakness
Systematic review and meta-analysisCombines all good trialsCochrane review of anti-VEGF for DMEOnly as good as the included trials; publication bias (funnel plot asymmetry)
Randomised controlled trialRandom allocation removes confoundingLiGHT (SLT vs drops), Protocol TCost, strict selection limits generalisability
Cohort studyFollows exposed and unexposed people forwardSmokers vs non-smokers for cataractConfounding, loss to follow-up
Case–control studyCompares cases with controls, looking back at exposuresUveal melanoma and sunlightRecall and selection bias
Cross-sectional studyMeasures prevalence at one time pointPrevalence of glaucoma in a districtCannot show cause and effect
Case series and case reportsDescribe new findingsFirst reports of a drug side effectNo comparison group

Common biases

  • Selection bias: the study population does not represent the target population (for example, tertiary hospital patients used to estimate community prevalence).
  • Lead-time bias: earlier diagnosis by screening makes survival look longer even if outcome is unchanged. Length-time bias: screening picks up slower, milder disease.
  • Recall bias (case–control studies), observer bias (reduced by masking), attrition bias (dropouts), and publication bias.
  • Confounding: a third factor linked to both exposure and outcome (for example, age in studies of diabetes and cataract). Randomisation, matching and multivariable analysis reduce it.

Trials: key terms

  • Intention-to-treat: analyse people in the groups they were randomised to, whatever happened; preserves randomisation. Per-protocol: only those who completed treatment as planned.
  • Masking (blinding): single (patient), double (patient and assessor). Non-inferiority trials test whether a new treatment is not worse than the standard by more than a set margin (for example faricimab vs aflibercept).
  • Survival analysis: Kaplan–Meier curves for time-to-event data such as graft survival or trabeculectomy failure, compared with the log-rank test; hazard ratios from Cox regression.

Agreement and reliability

  • Bland–Altman plot: agreement between two measurement methods (for example two tonometers): plots the difference against the mean, with the mean bias and 95% limits of agreement. Correlation is not agreement.
  • Kappa statistic: agreement between observers beyond chance for categories (for example grading of diabetic retinopathy): above 0.8 is very good, 0.6–0.8 good.
  • Intraclass correlation: reliability of continuous measurements.

Research ethics and consent

  • The Declaration of Helsinki sets the principles for research involving people; studies need ethics committee approval and informed consent. In India, research follows the ICMR National Ethical Guidelines and trials are registered with CTRI.
  • Consent for treatment: patients must be told about material risks, benefits and reasonable alternatives (UK: Montgomery 2015). Record the discussion, not just a signature.
  • Confidentiality can be broken only in limited situations, such as serious risk to others (for example an unsafe driver who refuses to stop).

Related: landmark trials, thesis topics, how to write a case report.

Key sources

  • Kirkwood BR, Sterne JAC. Essential Medical Statistics, 2nd ed. Blackwell; 2003
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10
  • Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017
  • World Medical Association. Declaration of Helsinki (2024 revision)

📘 Want more exam-ready material? See Most Commons in Ophthalmology on Kindle, or browse all my books.

How to cite this page

Patel D. Biostatistics and Research Methods for Ophthalmologists. RPC Rounds (Sadbhaav Eye Clinic). Updated October 2026. Available at: https://www.sadbhaavclinic.com/biostatistics-for-ophthalmologists.html. Accessed [date].

Written and medically reviewed by Dr. Dhaval Patel, MD (Ophthalmology, AIIMS New Delhi) · Editorial policy

Consultant, Cataract & Refractive Surgery — among a small number of AIIMS-trained ophthalmologists practicing in Gujarat. Read full credentials & experience or view his 28 publications on ResearchGate.

📚 Also the author of OKAT Decoded, FRCOphth Decoded and other high-yield ophthalmology exam-prep books used by residents and PG aspirants.

Looking for an eye specialist in Ahmedabad? Learn about our Eye Department or book a consultation with Dr. Dhaval Patel.